Skip to main content
SpringerLink
Log in

Synergistic anticonvulsant effects of pregabalin and amlodipine on acute seizure model of epilepsy in mice

  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Status epilepticus is a life threatening neurological medical emergency. It may cause serious damage to the brain and even death in many cases if not treated properly. There is limited choice of drugs for the short term and long term management of status epilepticus and the dugs recommended for status epilepticus possess various side effects. The present study was designed to investigate synergistic anticonvulsant effects of pregabalin with amlodipine on acute seizure model of epilepsy in mice. Pentylenetetrazole was used to induce acute seizures which mimic status epilepticus. Pregabalin and amlodipine were used in combination to evaluate synergistic anti-seizure effects on acute seizure model of epilepsy in mice. Diazepam and valproate were used as reference dugs. The acute anti-convulsive activity of pregabalin with amlodipine was evaluated in vivo by the chemical induced seizures and their anti-seizure effects were compared with pentylenetetrazole, reference drugs and to their individual effects. The anti-seizure effects of tested drugs were recorded in seconds on seizure characteristics such as latency of onset of threshold seizures, rearing and fallings and Hind limbs tonic extensions. The seizure protection and mortality to the animals exhibited by the drugs were recorded in percentage. Combination regimen of pregabalin with amlodipine exhibited dose dependent significant synergistic anticonvulsant effects on acute seizures which were superior to their individual effects and equivalent to reference drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Aminoff MJ, Simon RP (1980) Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 69:657–666

    Article  CAS  PubMed  Google Scholar 

  • Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S (2004) Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled and dose–response study in adults with partial seizures. Epilepsia 45:20–27

    Article  CAS  PubMed  Google Scholar 

  • Asconape JJ (2002) Some common issues in the use of antiepileptic drugs. Semin Neurol 22:27–39

    Article  PubMed  Google Scholar 

  • Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA (2005) Pregabalin 1008–009 study group. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64:475–480

    Article  CAS  PubMed  Google Scholar 

  • Bian F, Li Z, Offord J, Davis MD, McCormick J, Taylor CP, Walker LC (2006) Calcium channel alpha 2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo auto-radiographic study in alpha 2-delta type 1 genetically modified mice. Brain Res 1075:68–80

    Article  CAS  PubMed  Google Scholar 

  • Borowicz KK, Czuczwar SJ (2007) Effects of three calcium channel antagonists (amlodipine, diltiazem and verapamil) on the protective action of lamotrigine in the mouse maximal electroshock-induced seizure model. Pharmacol Rep 59:672–682

    PubMed  Google Scholar 

  • Brandt L, Saveland H, Ljunggre B, Andersson KE (1988) Control of epilepsy partialis continuans with intravenous nimodipine: report of two cases. J Neurol 69:949–950

    CAS  Google Scholar 

  • Brodie MJ (2004) Pregabalin as adjunctive therapy for partial seizures. Epilepsia 45:19–27

    Article  CAS  PubMed  Google Scholar 

  • Brodie MJ, Wilson EA, Wesche DL, Alvey CW, Randinitis EJ, Posvar EL, Bockbrader HN (2005) Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 46:1407–1413

    Article  CAS  PubMed  Google Scholar 

  • Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Treiman DM (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17:3–23

    Article  PubMed  Google Scholar 

  • Burges R, Moisey D (1994) Unique pharmacologic properties of amlodipine. Am J Cardiol 73:A2–A9

    Article  Google Scholar 

  • Czuczwar SJ, Borowicz KK (2002) Polytherapy in epilepsy: the experimental evidence. Epilepsy Res 52:15–23

    Article  CAS  PubMed  Google Scholar 

  • Delgado-Escueta AV, Bajorek JG (1982) Status epilepticus: mechanisms of brain damage and rational management. Epilepsia 23:S29–S41

    Article  PubMed  Google Scholar 

  • Derivan AT, Homan RW, Walker J, Ramsay RE, Patric B (1983) Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 249:1452–1454

    Article  PubMed  Google Scholar 

  • Falco FA, Bartiromo U, Majello L, Geronimo G, Mundo P (1992) Calcium antagonist nimodipine in intractable epilepsy. Epilepsia 33(2):343–345

    Article  PubMed  Google Scholar 

  • Fisher RS (1989) Animal models of the epilepsies. Brain Res Rev 14(3):245–278

    Article  CAS  PubMed  Google Scholar 

  • Frampton JE, Foster RH (2005) Pregabalin: in the treatment of postherpetic neuralgia. Drugs 65(1):111–118; discussion 119–120

  • Franco V, French JA, Perucca E (2016) Challenges in the clinical development of new antiepileptic drugs. Pharmacol Res 103:95–104

    Article  PubMed  Google Scholar 

  • Gatti G, Bonomi I, Jannuzzi G, Perucca E (2000) The new antiepileptic drugs pharmacological and clinical aspects. Curr Pharm Des 6(8):839–860

    Article  CAS  PubMed  Google Scholar 

  • Grone BP, Baraban SC (2015) Animal models in epilepsy research: legacies and new directions. Nat Neurosci 18(3):339–343

  • Hamandi K, Sander JW (2006) Pregabalin: a new antiepileptic drug for refractory epilepsy. Seizure 15:73–78

    Article  PubMed  Google Scholar 

  • Hauser WA (1983) Status epilepticus: frequency, etiology, and neurological sequelae. Adv Neurol 34:3–14

    CAS  PubMed  Google Scholar 

  • Huguenard JR (1996) Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol 58:329–348

    Article  CAS  PubMed  Google Scholar 

  • Iftinca MC, Zamponi GW (2009) Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci 30:32–40

    Article  CAS  PubMed  Google Scholar 

  • Janis RA, Triggle DJ (1983) New developments in calcium ion channel antagonists. J Med Chem 26:775–785

    Article  CAS  PubMed  Google Scholar 

  • Kaminski RM, Mazurek M, Turski WA, Kleinrok Z, Czuczwar SJ (2001) Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures. Pharmacol Biochem Behav 68:661–668

    Article  CAS  PubMed  Google Scholar 

  • Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruqqiero RN, Umeoka EH, Garcia-Cairasco N, Bueno-Junior LS, Leite JP (2014) Animal models of epilepsy: use and limitations. Neuropsychiatr Dis Treat 10:1693–1705

    Article  PubMed  PubMed Central  Google Scholar 

  • Khanna N, Bhalla S, Verma V, Sharma KK (2000) Modulatory effects of nifedipine and nimodipine in experimental convulsions. Indian J Pharm 32:347–352

    CAS  Google Scholar 

  • Khosravani H, Zamponi GW (2006) Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 86:941–966

    Article  CAS  PubMed  Google Scholar 

  • Knake S, Hamer HM, Rosenow F (2009) Status epilepticus: A critical review. Epilepsy Behav 15:10–14

    Article  PubMed  Google Scholar 

  • Kulak W, Sobaniec W, Wojtal K, Czuczwar SJ (2004) Calcium modulation in epilepsy. Pol J Pharmacol 56:29–41

    Article  CAS  PubMed  Google Scholar 

  • Kwan P, Sills GJ, Brodie MJ (2001) The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther 90:21–34

    Article  CAS  PubMed  Google Scholar 

  • Loscher W, Schmidt D (2002) New horizons in the development of antiepileptic drugs. Epilepsy Res 50:3–16

    Article  CAS  PubMed  Google Scholar 

  • Luszczki JJ, Czuczwar SJ (2004) Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study. Naunyn-Schm Arch pharmacol 369:434–446

    Article  CAS  Google Scholar 

  • Luszczki JJ, Andres MM, Czuczwar SJ (2005) Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model—an isobolographic analysis. Eur J Pharmacol 515:54–61

    Article  CAS  PubMed  Google Scholar 

  • Luszczki JJ, Trojnar MK., Trojnar M.P, Kimber-Trojnar Z, Szostakiewic B, Zadrozniak A, Czuczwar SJ. Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice presented in part at the 11th congress of the European Federation of Neurological Societies, Brussels, Belgium, 25-28 august 2007. Can J Physiol Pharmacol 2008; 86:113–121.

  • Macdonald RL, Kelly KM (1994) Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 35:S41–S50

    Article  PubMed  Google Scholar 

  • Meyer FB, Anderson RE, Sundt TM (1990) Anticonvulsant effects of dihydropyridine Ca2+ antagonists in electro-cortical shock seizures. Epilepsia 31:68–74

    Article  CAS  PubMed  Google Scholar 

  • Morocutti C, Pierelli F, Sanarelli L, Stefano E, Peppe A, Mattioli GL (1986) Antiepileptic effects of a calcium antagonist (nimodipine) on cefazolin-induced epileptogenic foci in rabbits. Epilepsia 27:498–503

    Article  CAS  PubMed  Google Scholar 

  • Moshe SL, Perucca E, Ryvlin P, Tomson T (2015) Epilepsy: new advances. Lancet 385:884–898

    Article  PubMed  Google Scholar 

  • National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, pp. 1–7

  • Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B, White BG (1984) Antiepileptic drug development program. Cleveland Clinic Quarterly 51(2):293–305

    Article  CAS  PubMed  Google Scholar 

  • Raines A, Henderson TR, Swinyard EA, Dretchen KL (1990) Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus. Epilepsia 31(3):313–317

    Article  CAS  PubMed  Google Scholar 

  • Raj D, Gulati S, Lodha R (2011) Status epilep. Indian J Pediatr 78(2):219–226

    Article  PubMed  Google Scholar 

  • Reddy DS, Kuruba R (2013) Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions. Int J Mol Sci 14(9):18284–18318

    Article  PubMed  PubMed Central  Google Scholar 

  • Rubio C, Rubio-Osornio M, Retana-Márquez S, López M, Custodio V, Paz C (2010) In vivo experimental models of epilepsy. Cent Nerv Syst Agents Med Chem 10(4):298–309

    Article  CAS  PubMed  Google Scholar 

  • Ryvlin P, Perucca E, Rheims S (2008) Pregabalin for the management of partial epilepsy. Neuro psychiatr Dis Treat 4(6):1211–1224

    Article  CAS  Google Scholar 

  • Shneker BF, McAuley JW (2005) Pregabalin: a new neuromodulator with broad therapeutic indications. Ann Pharmacother 39:2029–2037

    Article  CAS  PubMed  Google Scholar 

  • Sills GJ (2006) The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol l6:108–113

    Article  Google Scholar 

  • Stafstrom CE (2010) Mechanisms of action of antiepileptic drugs: the search for synergy. Curr Opin Neurol 23:157–163

    Article  CAS  PubMed  Google Scholar 

  • Taylor CP, Angelotti T, Fauman E (2007) Pharmacology and mechanism of action of pregabalin: the calcium channel α 2–δ (alpha 2–delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73:137–150

    Article  CAS  PubMed  Google Scholar 

  • Triggle DJ (2007) Calcium channel antagonists: clinical uses—past, present and future. Biochem Pharmacol 74:1–9

    Article  CAS  PubMed  Google Scholar 

  • Zapater P, Javaloy J, Roman JF, Vidal MT, Horga JF (1998) Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice. Brain Res 796:311–314

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, 75270, Pakistan

    Itefaq Hussain Qureshi, Azra Riaz & Rafeeq Alam Khan

  2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, 75270, Pakistan

    Afaq Ahmed Siddiqui

Authors
  1. Itefaq Hussain Qureshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Azra Riaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rafeeq Alam Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Afaq Ahmed Siddiqui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rafeeq Alam Khan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qureshi, I.H., Riaz, A., Khan, R.A. et al. Synergistic anticonvulsant effects of pregabalin and amlodipine on acute seizure model of epilepsy in mice. Metab Brain Dis 32, 1051–1060 (2017). https://doi.org/10.1007/s11011-017-9979-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-017-9979-2

Keywords

Search

Navigation